Pharmaceuticals - Community Register


Community register of veterinary medicinal products


Product information

Invented name: Nobivac Bb   
Auth. number : EU/2/02/034
Active substance : Not available
ATC: Anatomical main group: QI - Immunologicals
Therapeutic subgroup: QI06 - Immunologicals for felidae
Pharmacological subgroup: QI06A - Cat
Chemical subgroup: QI06AE - Live bacterial vaccines
Chemical substance: QI06AE02 - bordetella
(See WHO ATCvet Index)
Indication: For active immunisation of cats, of 1 month of age or older to reduce clinical signs of Bordetella
bronchiseptica associated upper respiratory tract disease.
Onset of immunity: Onset of immunity was established in 8 week old cats as early as 72 hours after
Duration of immunity: The duration of immunity is up to 1 year.
No data on the influence of maternal antibodies on the effect of vaccination with Nobivac Bb for cats are
available. From literature it is considered that this type of intranasal vaccine is able to induce an immune
response without interference from maternally derived antibodies.
Marketing Authorisation Holder: Intervet International B.V.
Wim de Körverstraat 35, 5831 AN Boxmeer, Nederland
EPAR and active package presentations

Package presentations

Information about presentations can be found in the website of the European Medicines Agency under the section "Product Information".
Likewise, presentations on which there has been a Commission decision are referred in the Summary of Product Characteristics (Annex I to the Commission Decision granting the marketing authorisation) which is available in the Community Register.

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
12/09/2002 Centralised - Authorisation EMEA/V/C/68/1 (2002)3379 of 10/09/2002
11/04/2003 Centralised - Variation EMEA/V/C/68/I/1 (2003)1247 of 09/04/2003
29/01/2004 Centralised - Variation EMEA/V/C/68/II/2 (2004)219 of 27/01/2004
23/03/2004 Centralised - Notification EMEA/V/C/68/N/3 (2004)1051 of 19/03/2004
29/11/2004 Centralised - Variation EMEA/V/C/68/II/4 (2004)4626 of 25/11/2004
23/05/2005 Centralised - Variation EMEA/V/C/68/IB/5
Updated with Decision(2006)154 of 20/01/2006
24/01/2006 Centralised - Variation (2006)154 of 20/01/2006
27/09/2007 Centralised - Renewal EMEA/V/C/68/R/6 (2007)4486 of 25/09/2007
25/07/2008 Centralised - Variation (no change in Commission Decision) EMEA/V/C/68/II/7
25/07/2008 Centralised - Variation (no change in Commission Decision) EMEA/V/C/68/II/8
08/06/2010 Centralised - Variation (no change in Commission Decision) EMEA/V/C/68/IG/1
03/09/2012 Centralised - Renewal EMEA/V/C/68/R/10 (2012)6134 of 30/08/2012
17/10/2014 Centralised - Variation EMEA/V/C/68/IA/12
Updated with Decision(2015)7924 of 09/11/2015
11/11/2015 Centralised - Yearly update (2015)7924 of 09/11/2015